Cellyan Biotechnology Co., Ltd (HKPD) vs INVO Fertility, Inc. (IVF)
A side-by-side comparison of Cellyan Biotechnology Co., Ltd and INVO Fertility, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HKPD
Cellyan Biotechnology Co., Ltd
$0.10HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
IVF
INVO Fertility, Inc.
$0.81HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT
Total return — HKPD vs IVF
growth of $100 · dividends reinvested · last 2yHKPD -96.3% (-80.8%/yr)IVF -99.9% (-97.4%/yr)HKPD compounded faster over this window
Log scale — wide-divergence pair
HKPD IVF
HKPD vs IVF: by the numbers
- •IVF is the larger company ($1M vs $1M market cap).
- •Both run net losses; HKPD's is the smaller (-8.46% vs -70.18% net margin).
Metrics side by side
Valuation
| Metric | HKPD | IVF |
|---|---|---|
| P/S ratio | N/A | 0.19 |
| P/B ratio | 0.11 | 0.09 |
Profitability
| Metric | HKPD | IVF |
|---|---|---|
| Gross margin | 10.32% | 33.34% |
| Operating margin | -7.41% | -78.72% |
| Net margin | -8.46% | -70.18% |
| ROE | -11.85% | -32.05% |
| ROIC | -9.45% | -28.43% |
Growth (annualized)
| Metric | HKPD | IVF |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 39.51% |
| Total return CAGR (5Y) | N/A | -90.41% |
Go deeper
Dig into the metrics
Cellyan Biotechnology ROEINVO Fertility ROECellyan Biotechnology operating marginINVO Fertility operating marginCellyan Biotechnology revenue growthINVO Fertility revenue growthCellyan Biotechnology free cash flowINVO Fertility free cash flow
Cellyan Biotechnology & INVO Fertility appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.